title: Therapeutic efficacy of N-methyl D-aspartate antagonist amantadine in febrile catatonia.
authors.forename: G
authors.initials: G
authors.lastname: Northoff
authors.forename: H
authors.initials: H
authors.lastname: Lins
authors.forename: H
authors.initials: H
authors.lastname: Böker
authors.forename: P
authors.initials: P
authors.lastname: Danos
authors.forename: B
authors.initials: B
authors.lastname: Bogerts
mesh_terms: D000328:Adult; D000547:Amantadine / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000150:complications / Q000188:drug therapy; D002389:Catatonia / Q000188:drug therapy* / Q000209:etiology; D015259:Dopamine Agents / Q000627:therapeutic use*; D018690:Excitatory Amino Acid Agonists / Q000627:therapeutic use*; D005334:Fever / Q000150:complications*; D006801:Humans; D008297:Male; D016202:N-Methylaspartate / Q000037:antagonists & inhibitors*; D011618:Psychotic Disorders / Q000150:complications / Q000188:drug therapy
chemical_list: D015259:Dopamine Agents; D018690:Excitatory Amino Acid Agonists; D016202:N-Methylaspartate; D000547:Amantadine